As part of its ongoing expansion strategy in nutrition and health, Lesaffre, a key global company in the field of yeast and fermentation, announces a majority participation in Gnosis, an Italian company specialising in the development, production and sale of fermentation ingredients for the pharmaceutical, nutraceutical, cosmetic and veterinary industries. Read more
Today, the tremendous potential of the yeasts and natural yeast by-products that Lesaffre makes and markets provides a response to some of the major issues of the 21st century, in terms of health and nutrition, the environment, energy and more.
This potential stands out as an asset in addressing the new challenges facing industrialists, as well as the health, well-being and pleasure of the planet’s consumers.
Through these activities and the work of our dedicated business units, Lesaffre helps to use advances in biotechnology to create a cleaner, more sustainable world.